State-of-the-art enzyme engineering by structure-based modelling techniques
Enzymatic processes are key to providing biotechnological solutions in the immediate future of our society, tackling clean energy production, bioremediation...
Why it’s important to get the right lead molecule
The success of a new drug campaign is highly dependent on the selection of lead series very early on in the drug discovery process. Find out how we can help!
Emerging trends: Covalent inhibitors
With over 50 approved drugs currently on the market, covalent inhibitors seem to be a hot topic! Find out what all the fuss is about and we’re doing to stay on top of things.
PyDock featured in HiPEAC magazine
We are in the January issue of the HiPEAC magazine, presenting our PyDock technology for drug design and discovery.
Check it out!
Javier Iglesias appointed as the new leader of the Enzyme Engineering division
Dr. Iglesias, who recently joined NBD as Project Manager for the Nucleic Acids Division, has been internally promoted to substitute the...
New exciting publication from our Enzyme Engineering division: glycosyltransferase catalysis
Check the new article of our employee Joan Coines, in which he engineered a glycosyltransferase able to efficiently catalyze N-, O- or S-glycosylation.